Pill-sized imaging device could improve Barrett's screening

Physicians may soon have a new way to screen patients for Barrett’s oesophagus, a pre-cancerous condition usually caused by chronic exposure to stomach acid.

Researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) have developed an imaging system enclosed in a small capsule that creates detailed, microscopic images of the oesophageal wall.

The system is claimed to have several advantages over traditional endoscopy.

‘This system gives us a convenient way to screen for Barrett’s that doesn’t require patient sedation, a specialised setting and equipment or a physician who has been trained in endoscopy,’ said Prof Gary Tearney of the Wellman Center and the MGH Pathology Department and corresponding author of a report on the development in Nature Medicine. ‘By showing the three-dimensional, microscopic structure of the oesophageal lining, it reveals much more detail than can be seen with even high-resolution endoscopy.’

The system developed by Tearney and his colleagues involves a capsule containing optical frequency domain imaging (OFDI) technology, a rapidly rotating laser tip emitting a beam of near-infrared light and sensors that record light reflected back from the oesophageal lining.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox